-
- Positions
- PROFESSOR | Medicine, Cardiology
- PROFESSOR | Population Health Science and Policy
-
- Specialty
- Cardiology
-
- Languages
- English
- Spanish
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- 212-659-9691212-659-9691
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine. Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was also a Chief Medical Resident, before continuing with Fellowships in Cardiovascular Disease and Interventional Cardiology at Mount Sinai Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology and for her experience and expertise in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author and frequent invited speaker at national and international scientific conferences such as American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR. She has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years. Dr. Mehran serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, and Circulation Research. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative, and is also the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation (NYC).
Certifications
Interventional Cardiology
Cardiovascular Disease
Clinical Focus
- Acute Coronary Syndrome
- Angina
- Cardiac Catheterization
- Coronary Artery Disease
- Coronary Stenting
- High Blood Pressure
- High Cholesterol
- Hyperlipidemia
Education
MD, St. George's University
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Internal Medicine
University of Connecticut
Fellowship, Cardiovascular Med
Mount Sinai Hospital
Fellowship, Intervent Cardiology
Mount Sinai Hospital
Languages
English, Spanish
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Mehran during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- AstraZeneca
- Bayer
- CSL Behring
- Janssen Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Osprey Medical Inc.
- Regado Biosciences, Inc.
- The Medicines Company
- Watermark Consulting
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Claret Medical Inc.
- Elixir Medical Corporation
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- PlatformQ
- sanofi-aventis
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Covidien
Scientific Advisory Board:
- Abbott Laboratories
- AstraZeneca
- Boston Scientific Corporation
- Covidien
- Janssen Pharmaceuticals, Inc.
- Merck & Co., Inc.
- The Medicines Company
- sanofi-aventis
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.